{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:48:13Z","timestamp":1761745693418,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Elevated blood glucose and CRP (C-reactive protein) are usually related to a worsened clinical outcome in neurological diseases. This association in Guillain-Barr\u00e9 syndrome (GBS) has been studied rarely. We tried to analyse if hyperglycaemia and CRP at admission may influence the outcome of GBS, including mechanically ventilated (MV) patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively studied 66 patients (40 males, 19\u201393 years, average 56 years) without diabetes mellitus and free of corticoid treatment, who fulfilled the clinical criteria for diagnosis of GBS. Hyperglycaemia (the level of fasting plasma glucose, FPG) was defined as blood glucose level &amp;gt;5.59 mmol\/L according to our laboratory. CRP &amp;gt;5 mg\/L was considered as an abnormally elevated value.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At admission, 32 GBS patients (48%) had hyperglycaemia according to FPG level. A severe form of GBS (&amp;gt;4 according to Hughes GBS scale) was observed in 17 patients (26%); and 8 of them (47%) had hyperglycaemia. Fourteen patients (21%) were MV, and in 10 of them (71%) hyperglycaemia was present. CRP was significantly increased in MV patients. The linear model revealed a significant relationship between CRP and glycemia (<jats:italic>p<\/jats:italic> = 0.007) in subjects without MV (<jats:italic>p<\/jats:italic> = 0.049). In subjects with MV the relationship was not significant (<jats:italic>p<\/jats:italic> = 0.2162, NS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In the acute phase of GBS at admission, hyperglycaemia and higher CRP occur relatively frequently, and may be a risk factor for the severity of GBS. Stress hyperglycaemia due to impaired glucose homeostasis could be one explanation for this condition.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.875714","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T05:03:55Z","timestamp":1653282235000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Influence of Hyperglycaemia and CRP on the Need for Mechanical Ventilation in Guillain-Barr\u00e9 Syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Ivana","family":"\u0160t\u011btk\u00e1\u0159ov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edvard","family":"Ehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"\u017did\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Pol\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u0159\u00ed","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1\u0161","family":"Peisker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain- Barr\u00e9 syndrome: a systematic review and meta- analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain-Barre syndrome worldwide. A systematic literature review","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"Van den Berg","year":"2014","journal-title":"Nat Rev Neurol."},{"key":"B5","first-page":"565","article-title":"Criteria for diagnosis of Guillain- Barr\u00e9 syndrome","volume":"3","author":"Asbury","year":"1978","journal-title":"Ann Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain- Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1385\/NCC:1:4:415","article-title":"Respiratory dysfunction in Guillain-Barr\u00e9 Syndrome","volume":"1","author":"Orlikowski","year":"2004","journal-title":"Neurocrit Care."},{"key":"B9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/brain\/awy232","article-title":"Regional variation of Guillain-Barr\u00e9 syndrome","volume":"141","author":"Doets","year":"2018","journal-title":"Brain."},{"key":"B11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.metabol.2016.11.011","article-title":"Stress hyperglycemia and acute ischemic stroke in-hospital outcome","volume":"67","author":"Tziomalos","year":"2017","journal-title":"Metabolism."},{"key":"B12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.STR.0000115297.92132.84","article-title":"Hyperglycemia in acute stroke","volume":"35","author":"Lindsberg","year":"2004","journal-title":"Stroke."},{"key":"B13","doi-asserted-by":"publisher","first-page":"785428","DOI":"10.3389\/fneur.2021.785428","article-title":"Association of stress hyperglycemia ratio with acute ischemic stroke outcomes post-thrombolysis","volume":"12","author":"Shen","year":"2022","journal-title":"Front Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/(SICI)1099-0895(199709)13:3<163::AIDDMR189>3.0.CO;2-Z","article-title":"Gangliosides and autoimmune diabetes","volume":"13","author":"Misasi","year":"1997","journal-title":"Diabetes Metab Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00415-010-5836-5","article-title":"The role of cytokines in Guillain-Barr\u00e9 syndrome","volume":"258","author":"Lu","year":"2011","journal-title":"J Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0145075","DOI":"10.1371\/journal.pone.0145075","article-title":"Fasting glucose levels correlate with disease severity of Guillain-Barr\u00e9 syndrome","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS ONE."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.2169\/internalmedicine.50.5553","article-title":"A Case of diabetic ketoacidosis associated with Guillain-Barr\u00e9 syndrome","volume":"50","author":"Kanemasa","year":"2011","journal-title":"Intern Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1007\/s10072-020-04930-4","article-title":"Clinical value of C-reactive protein\/albumin ratio in Guillain-Barr\u00e9 syndrome","volume":"42","author":"Ning","year":"2021","journal-title":"Neurol Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41983-018-0006-2","article-title":"Correlative study between C-reactive protein, clinical severity, and nerve conduction studies in Guillain-Barre syndrome","volume":"54","author":"Altaweel","year":"2018","journal-title":"Egypt J Neurol Psychiatr Neurosurg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"300060520904842","DOI":"10.1177\/0300060520904842","article-title":"Correlations between microRNA-146a and immunoglobulin and inflammatory factors in Guillain-Barr\u00e9 syndrome","volume":"48","author":"Huang","year":"2020","journal-title":"J Int Med Res."},{"key":"B21","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial of prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"B22","unstructured":"R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing2014"},{"key":"B23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/cc12514","article-title":"Bellomo R. Stress hyperglycemia: an essential survival response!","volume":"17","author":"Marik","year":"2013","journal-title":"Crit Care."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182904fcc","article-title":"Mortality in Guillain- Barr\u00e9 syndrome","volume":"80","author":"Van den Berg","year":"2013","journal-title":"Neurology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1212\/01.wnl.0000310983.38724.d4","article-title":"Guillain\u2013Barr\u00e9 syndrome: incidence and mortality rates in US hospitals","volume":"70","author":"Alshekhlee","year":"2008","journal-title":"Neurology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1097\/CCM.0000000000003635","article-title":"Dysglycemia and neurologic outcome in mechanically ventilated patients with Guillain-Barr\u00e9 syndrome","volume":"47","author":"Polito","year":"2019","journal-title":"Crit Care Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s13760-019-01133-3","article-title":"Early predictors of functional disability in Guillain-Barre syndrome","volume":"119","author":"Tunc","year":"2019","journal-title":"Acta Neurol Belg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2147\/NDT.S162896","article-title":"Effect of serum inflammatory markers on the prognosis of adult and pediatric patients with Guillain-Barre syndrome","volume":"14","author":"Ethemoglu","year":"2018","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6671043","DOI":"10.1155\/2021\/6671043","article-title":"C-reactive protein levels and clinical prognosis in LAA-type stroke patients: a prospective cohort study","volume":"2021","author":"Zeng","year":"2021","journal-title":"Biomed Res Int."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.875714\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T05:03:58Z","timestamp":1653282238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.875714\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":29,"alternative-id":["10.3389\/fneur.2022.875714"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.875714","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"article-number":"875714"}}